Boston-based digital surgery company Zeta Surgical announced on Wednesday that its Zeta Navigation System has received 510(k) clearance from the US Food and Drug Administration (FDA) for use with expanded instruments and enhanced hospital connectivity.
The Zeta Surgical platform is designed to provide rapidly deployable, high-accuracy navigation for neurological interventions currently unsupported by existing navigation systems. Its guidance system uses mixed reality and advanced motion-aware remote sensing to enable real-time patient tracking, providing access to navigation across a wide range of neurological interventions.
This latest FDA approval enables the Zeta system to be deployed with a variety of new accessories and surgical kits, including instruments from IZI Medical. It will also allow hospitals to integrate the system's software into their IT networks, allowing for seamless and fast access to patient data.
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea
AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment
US FDA approves expanded indication for AbbVie's MAVYRET (glecaprevir/pibrentasvir) in acute HCV
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Psilera collaborates with Hesperos for PSIL-006 preclinical modelling for frontotemporal dementia
Myosin Therapeutics' MT-125 cleared by US FDA to initiate first-in-human trial in glioblastoma
Ondine's Steriwave proven effective against deadly Mucor fungus
AB Science receives EMA approval to extend Masivet shelf life to four years
Hemispherian's GLIX1 receives positive EU opinion for orphan designation in glioma
Arvinas and Pfizer submit FDA application for vepdegestrant in ESR1-mutated breast cancer
NRx Pharmaceuticals files ANDA for preservative-free IV ketamine
Innovent's IBI363 granted second breakthrough therapy designation in China
Implantica reports positive NICE guidance for RefluxStop procedure in UK hospitals